Evaluation of A Post-Treatment Follow-Up Program in Patients with Oral Squamous Cell Carcinoma [PDF]
, 2016 Objectives The duration and the frequency of follow-up after treatment of oral squamous cell carcinoma are not standardized in the current literature.
Guentsch, Arndt +5 more
core +2 more sources
Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: an update with special reference to HPV-related carcinomas [PDF]
, 2014 Accurate identification of the microscopic risk factors of oral and oropharyngeal (OP) squamous cell carcinomas (SCC) and their morphologic variants is of at most importance, as these generally determine treatment modalities, prognosis and overall ...
El Mofty, Samir K
core +1 more source
Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
Case Reports in Otolaryngology, 2022 Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An asymptomatic neck mass in adults may be the only clinical sign of head and neck cancer.
Alexander Karatzanis +4 more
doaj +1 more source
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. [PDF]
, 2016 Purpose Treatment with pembrolizumab, an anti-programmed death-1 antibody, at 10 mg/kg administered once every 2 weeks, displayed durable antitumor activity in programmed death-ligand 1 (PD-L1) -positive recurrent and/or metastatic (R/M) head and neck ...
Berger, Raanan +21 more
core +2 more sources
Head and neck squamous cell carcinoma survivorship care
Australian Journal of General Practice, 2019 Head and neck cancer is the seventh most commonly diagnosed cancer in Australia. More than 90% of these cancers are squamous cell carcinomas (SCCs). With advances in cancer therapies, survivorship care is becoming increasingly topical. In particular, general practitioners (GPs) will play an increasingly central part in the management of this unique ...
Joo, Koh +3 more
openaire +3 more sources
Hypoxia in Head and Neck Squamous Cell Carcinoma [PDF]
ISRN Otolaryngology, 2012 Hypoxia is a common feature in most of the solid tumors including head and neck squamous cell carcinoma (HNSCC). Hypoxia reflects the imbalance between oxygen consumption by the rapidly proliferating cancer cells and the insufficient oxygen delivery due to poor vascularization and blood supply.
John Zenghong Li +4 more
openaire +2 more sources
Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study [PDF]
, 2019 Background: More than 90% of malignant tumors diagnosed in the oral cavity are Oral Squamous Cell Carcinomas (OSCC) whose preferred location is the tongue.
Cebrián Carretero, José Luis +4 more
core +3 more sources
Cetuximab in squamous cell head and neck carcinomas
Annals of Oncology, 2007 The epidermal growth factor receptor (EGFR) antagonist, cetuximab, has recently been shown to enhance the effects of radiotherapy, and reports to date indicate that this effect occurs without any change in the pattern and severity of toxicity usually associated with head and neck radiation and/or chemotherapy (CT) administration.
GEBBIA, Vittorio +5 more
openaire +3 more sources
Tumor Biology, 2017 The aim of this study was to determine the methylation status of the genes encoding the vascular endothelial growth factor receptors and to evaluate the usefulness of VEGFR methylation as a prognostic indicator in head and neck squamous cell carcinoma ...
Yuki Misawa +10 more
doaj +1 more source
Circulating tumor cells in head and neck cancer: A review
World Journal of Otorhinolaryngology-Head and Neck Surgery, 2016 Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures ...
Kyle P. McMullen +4 more
doaj +1 more source